Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Pharmacokinetics of Rebamipide SR 150mg
NCT04150146Phase 1Completed
- Sponsor
- Otsuka Holdings
- Start
- Jul 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rebamipide in gastric ulcer and gastritis (2 arms), sponsored by Otsuka Holdings. Primary endpoints: Maximum Plasma Concentration at Day 9 and Area Under the Curve to Last Timepoint at Day 9. Started Jul 2019; status: completed.
02
Drugs
rebamipide
03
Conditions
gastric ulcergastritis
Beyond the preview
Go deeper on NCT04150146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150146.